{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:58:15Z","timestamp":1785455895032,"version":"3.56.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006701","name":"Umm Al-Qura University","doi-asserted-by":"publisher","award":["25UQU4350477GSSR01"],"award-info":[{"award-number":["25UQU4350477GSSR01"]}],"id":[{"id":"10.13039\/501100006701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00467-025-07102-8","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T02:52:24Z","timestamp":1765594344000},"page":"2711-2726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune dysregulation in pediatric cancer\u2013associated nephrotic syndrome: current insights"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7037-680X","authenticated-orcid":false,"given":"Noura A. A.","family":"Ebrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoraya A.","family":"Farghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-1073","authenticated-orcid":false,"given":"Soliman M. A.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"7102_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00467-024-06510-6","volume":"40","author":"C Bigatti","year":"2025","unstructured":"Bigatti C, Chiarenza DS, Angeletti A (2025) To biopsy or not to biopsy a teenager with idiopathic nephrotic syndrome? Biopsy first. Pediatr Nephrol 40:571\u2013578. https:\/\/doi.org\/10.1007\/s00467-024-06510-6","journal-title":"Pediatr Nephrol"},{"key":"7102_CR2","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.947393","volume":"31","author":"M Mitur-Lesiuk","year":"2025","unstructured":"Mitur-Lesiuk M, Dubaj M, Raniewicz M et al (2025) Review of paraneoplastic syndromes in children with malignancy. Med Sci Monit 31:e947393. https:\/\/doi.org\/10.12659\/MSM.947393","journal-title":"Med Sci Monit"},{"key":"7102_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","volume":"70","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Juillard L, Cochat P, Droz J-P (2009) Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol 70:39\u201358. https:\/\/doi.org\/10.1016\/j.critrevonc.2008.08.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"7102_CR4","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00467-024-06370-0","volume":"39","author":"CH Robinson","year":"2024","unstructured":"Robinson CH, Aman N, Banh T et al (2024) Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study. Pediatr Nephrol 39:2667\u20132677. https:\/\/doi.org\/10.1007\/s00467-024-06370-0","journal-title":"Pediatr Nephrol"},{"key":"7102_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000331211","volume":"4","author":"GM Poggi","year":"2011","unstructured":"Poggi GM, Fognani G, Cuzzubbo D et al (2011) Neuroblastoma presenting with acute kidney injury, hyponatremic-hypertensive-like syndrome and nephrotic proteinuria in a 10-month-old child. Case Rep Oncol 4:400\u2013405. https:\/\/doi.org\/10.1159\/000331211","journal-title":"Case Rep Oncol"},{"key":"7102_CR6","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0002-9440(10)64128-4","volume":"158","author":"S Doublier","year":"2001","unstructured":"Doublier S, Ruotsalainen V, Salvidio G et al (2001) Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 158:1723\u20131731. https:\/\/doi.org\/10.1016\/S0002-9440(10)64128-4","journal-title":"Am J Pathol"},{"key":"7102_CR7","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1182\/blood.V112.11.4832.4832","volume":"112","author":"S Dsilva","year":"2008","unstructured":"Dsilva S, Karayalcin G, Singh S (2008) Hodgkin disease and nephrotic syndrome, a rare paraneoplastic complication in children with literature review. Blood 112:4832\u20134832. https:\/\/doi.org\/10.1182\/blood.V112.11.4832.4832","journal-title":"Blood"},{"key":"7102_CR8","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","volume":"69","author":"V Audard","year":"2006","unstructured":"Audard V, Larousserie F, Grimbert P et al (2006) Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature. Kidney Int 69:2251\u20132260. https:\/\/doi.org\/10.1038\/sj.ki.5000341","journal-title":"Kidney Int"},{"key":"7102_CR9","first-page":"64","volume":"11","author":"D Sfrijan","year":"2016","unstructured":"Sfrijan D, Tieranu I, Necula I et al (2016) Nephrotic syndrome, paraneoplastic syndrome associated to Hodgkin lymphoma. Maedica (Buchar) 11:64\u201367","journal-title":"Maedica (Buchar)"},{"key":"7102_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000543334","volume":"5","author":"JA Jefferson","year":"2025","unstructured":"Jefferson JA, Chen K, Hingorani S et al (2025) Genetic and iatrogenic defects in peripheral tolerance associated with anti-nephrin antibody-associated minimal change disease. Glomerular Dis 5:74\u201383. https:\/\/doi.org\/10.1159\/000543334","journal-title":"Glomerular Dis"},{"key":"7102_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","volume":"33","author":"AJB Watts","year":"2022","unstructured":"Watts AJB, Keller KH, Lerner G et al (2022) Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol 33:238\u2013252. https:\/\/doi.org\/10.1681\/ASN.2021060794","journal-title":"J Am Soc Nephrol"},{"key":"7102_CR12","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1007\/s00467-025-06854-7","volume":"40","author":"Q Fu","year":"2025","unstructured":"Fu Q, Luo Y, Yao X, Wang H (2025) Alport syndrome complicated with steroid-sensitive nephrotic syndrome: a case report. Pediatr Nephrol 40:3651\u20133654. https:\/\/doi.org\/10.1007\/s00467-025-06854-7","journal-title":"Pediatr Nephrol"},{"key":"7102_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1053\/j.ajkd.2024.09.001","volume":"85","author":"CJ Fischman","year":"2025","unstructured":"Fischman CJ, Holzman LB (2025) Identification of nephrin autoantibodies signals new chapter for glomerular disease. Am J Kidney Dis 85:262\u2013265. https:\/\/doi.org\/10.1053\/j.ajkd.2024.09.001","journal-title":"Am J Kidney Dis"},{"key":"7102_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf100","volume":"18","author":"FE Hengel","year":"2025","unstructured":"Hengel FE, Huber TB, Tomas NM (2025) Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases. Clin Kidney J 18:sfaf100. https:\/\/doi.org\/10.1093\/ckj\/sfaf100","journal-title":"Clin Kidney J"},{"key":"7102_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.kint.2025.01.019","volume":"107","author":"FE Hengel","year":"2025","unstructured":"Hengel FE, Dehde S, Yilmaz A et al (2025) Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy. Kidney Int 107:1099\u20131103. https:\/\/doi.org\/10.1016\/j.kint.2025.01.019","journal-title":"Kidney Int"},{"key":"7102_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa2314471","volume":"391","author":"FE Hengel","year":"2024","unstructured":"Hengel FE, Dehde S, Lass\u00e9 M et al (2024) Autoantibodies targeting nephrin in podocytopathies. N Engl J Med 391:422\u2013433. https:\/\/doi.org\/10.1056\/NEJMoa2314471","journal-title":"N Engl J Med"},{"key":"7102_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.15171\/jnp.2017.32","volume":"6","author":"M Stangou","year":"2016","unstructured":"Stangou M, Spartalis \u039c, Daikidou D-V et al (2016) Impact of \u03a4h1 and \u03a4h2 cytokines in the progression of idiopathic nephrotic syndrome due to focal segmental glomerulosclerosis and minimal change disease. J Nephropathol 6:187\u2013195. https:\/\/doi.org\/10.15171\/jnp.2017.32","journal-title":"J Nephropathol"},{"key":"7102_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6499668","volume":"2022","author":"E Ahmadian","year":"2022","unstructured":"Ahmadian E, Rahbar Saadat Y, Dalir Abdolahinia E et al (2022) The role of cytokines in nephrotic syndrome. Mediators Inflamm 2022:6499668. https:\/\/doi.org\/10.1155\/2022\/6499668","journal-title":"Mediators Inflamm"},{"key":"7102_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47020077","volume":"47","author":"M Kopa\u010d","year":"2025","unstructured":"Kopa\u010d M, Jerin A, Petrera A, Osredkar J (2025) The role of cytokines and chemokines as biomarkers of disease activity in idiopathic nephrotic syndrome in children. Curr Issues Mol Biol 47:77. https:\/\/doi.org\/10.3390\/cimb47020077","journal-title":"Curr Issues Mol Biol"},{"key":"7102_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fendo.2018.00302","volume":"9","author":"CE Martin","year":"2018","unstructured":"Martin CE, Jones N (2018) Nephrin signaling in the podocyte: an updated view of signal regulation at the slit diaphragm and beyond. Front Endocrinol (Lausanne) 9:302. https:\/\/doi.org\/10.3389\/fendo.2018.00302","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7102_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s10157-025-02645-4","volume":"29","author":"T Horinouchi","year":"2025","unstructured":"Horinouchi T, Nozu K, Iijima K (2025) Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies. Clin Exp Nephrol 29:534\u2013540. https:\/\/doi.org\/10.1007\/s10157-025-02645-4","journal-title":"Clin Exp Nephrol"},{"key":"7102_CR22","unstructured":"New research demonstrates role of anti-nephrin autoantibodies as causative factor and disease activity biomarker in minimal change disease and idiopathic nephrotic syndrome (2024)\u00a0\u00a0https:\/\/www.is-gd.org\/en\/news-from-isgd\/anti-nephrin-autoantibodies-mcd-ins?utm. Accessed 08 Sept 2025"},{"key":"7102_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.kint.2023.11.022","volume":"105","author":"Y Shirai","year":"2024","unstructured":"Shirai Y, Miura K, Ishizuka K et al (2024) A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int 105:608\u2013617. https:\/\/doi.org\/10.1016\/j.kint.2023.11.022","journal-title":"Kidney Int"},{"key":"7102_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.kint.2024.08.004","volume":"106","author":"M Hattori","year":"2024","unstructured":"Hattori M (2024) Anti-nephrin autoantibodies: novel predictors of post-transplant recurrence of focal segmental glomerular sclerosis. Kidney Int 106:570\u2013572. https:\/\/doi.org\/10.1016\/j.kint.2024.08.004","journal-title":"Kidney Int"},{"key":"7102_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1681\/ASN.20233411S1309d","volume":"34","author":"A Weins","year":"2023","unstructured":"Weins A, Hamroun A, Provot F et al (2023) Pre-transplant nephrin autoantibodies predict post-transplant recurrent focal segmental glomerulosclerosis (FSGS). J Am Soc Nephrol 34:309\u2013309. https:\/\/doi.org\/10.1681\/ASN.20233411S1309d","journal-title":"J Am Soc Nephrol"},{"key":"7102_CR26","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK et al (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18:1476\u20131485. https:\/\/doi.org\/10.1681\/ASN.2006070710","journal-title":"J Am Soc Nephrol"},{"key":"7102_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00170","volume":"5","author":"R Bertelli","year":"2018","unstructured":"Bertelli R, Bonanni A, Caridi G et al (2018) Molecular and cellular mechanisms for proteinuria in minimal change disease. Front Med 5:170. https:\/\/doi.org\/10.3389\/fmed.2018.00170","journal-title":"Front Med"},{"key":"7102_CR28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s12098-010-0203-1","volume":"77","author":"P Farruggia","year":"2010","unstructured":"Farruggia P, Trizzino A, Maringhini S et al (2010) Hodgkin lymphoma and nephrotic syndrome in childhood. Indian J Pediatr 77:1147\u20131149. https:\/\/doi.org\/10.1007\/s12098-010-0203-1","journal-title":"Indian J Pediatr"},{"key":"7102_CR29","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1038\/s41598-025-86488-9","volume":"15","author":"B Ermian","year":"2025","unstructured":"Ermian B, Samieefar N, Vahidi A et al (2025) Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study. Sci Rep 15:4323. https:\/\/doi.org\/10.1038\/s41598-025-86488-9","journal-title":"Sci Rep"},{"key":"7102_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/lymphatics2010003","volume":"2","author":"Y Jadoon","year":"2024","unstructured":"Jadoon Y, Patil G, Loke C, Bhardwaj PV (2024) Paraneoplastic syndromes in Hodgkin\u2019s lymphoma. Lymphatics 2:25\u201342. https:\/\/doi.org\/10.3390\/lymphatics2010003","journal-title":"Lymphatics"},{"key":"7102_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-0041-1733244","volume":"28","author":"K Shreedhara Avabratha","year":"2007","unstructured":"Shreedhara Avabratha K, Rau ATK, Rau A (2007) Nephrotic syndrome associated with non Hodgkin\u2019s lymphoma. Indian J Med Paediatr Oncol 28:39\u201340","journal-title":"Indian J Med Paediatr Oncol"},{"key":"7102_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12882-018-0958-6","volume":"19","author":"B Gao","year":"2018","unstructured":"Gao B, Lin N, Wang S, Wang Y (2018) Minimal change disease associated with anti-PD1 immunotherapy: a case report. BMC Nephrol 19:156. https:\/\/doi.org\/10.1186\/s12882-018-0958-6","journal-title":"BMC Nephrol"},{"key":"7102_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/ped.13255","volume":"59","author":"S Tsuji","year":"2017","unstructured":"Tsuji S, Kimata T, Yamanouchi S et al (2017) Regulatory T cells and CTLA-4 in idiopathic nephrotic syndrome. Pediatr Int 59:643\u2013646. https:\/\/doi.org\/10.1111\/ped.13255","journal-title":"Pediatr Int"},{"key":"7102_CR34","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s10875-017-0446-y","volume":"37","author":"S Kostel Bal","year":"2017","unstructured":"Kostel Bal S, Haskologlu S, Serwas NK et al (2017) Multiple presentations of LRBA deficiency: a single-center experience. J Clin Immunol 37:790\u2013800. https:\/\/doi.org\/10.1007\/s10875-017-0446-y","journal-title":"J Clin Immunol"},{"key":"7102_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1408718","volume":"15","author":"D Zhang","year":"2024","unstructured":"Zhang D, Sun D (2024) Current progress in CAR-based therapy for kidney disease. Front Immunol 15:1408718","journal-title":"Front Immunol"},{"key":"7102_CR36","first-page":"1600","volume":"8","author":"E Elghoroury","year":"2016","unstructured":"Elghoroury E, Elsaeed G, Elshamaa M et al (2016) Fas-ligand and granzyme-b levels in children with nephrotic syndrome. Int J Pharm Clin Res 8:1600\u20131604","journal-title":"Int J Pharm Clin Res"},{"key":"7102_CR37","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","volume":"145","author":"VK Tesch","year":"2020","unstructured":"Tesch VK, Abolhassani H, Shadur B et al (2020) Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol 145:1452\u20131463. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.896","journal-title":"J Allergy Clin Immunol"},{"key":"7102_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000536194","volume":"10","author":"L Wu","year":"2024","unstructured":"Wu L, Feng Y, Huang Y et al (2024) CAR-T cell therapy: advances in kidney-related diseases. Kidney Dis 10:143\u2013152. https:\/\/doi.org\/10.1159\/000536194","journal-title":"Kidney Dis"},{"key":"7102_CR39","doi-asserted-by":"crossref","unstructured":"Cara-Fuentes GM, Johnson RJ, Garin EH (2016) Cytokines as active factors in minimal change nephrotic syndrome. In: Kaneko K (ed) Molecular mechanisms in the pathogenesis of idiopathic nephrotic syndrome. Springer Japan, Tokyo, pp 105\u2013140","DOI":"10.1007\/978-4-431-55270-3_8"},{"key":"7102_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12882-021-02257-6","volume":"22","author":"CS Curran","year":"2021","unstructured":"Curran CS, Kopp JB (2021) PD-1 immunobiology in glomerulonephritis and renal cell carcinoma. BMC Nephrol 22:80. https:\/\/doi.org\/10.1186\/s12882-021-02257-6","journal-title":"BMC Nephrol"},{"key":"7102_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00431-021-04357-9","volume":"181","author":"K Kitsou","year":"2022","unstructured":"Kitsou K, Askiti V, Mitsioni A, Spoulou V (2022) The immunopathogenesis of idiopathic nephrotic syndrome: a narrative review of the literature. Eur J Pediatr 181:1395\u20131404. https:\/\/doi.org\/10.1007\/s00431-021-04357-9","journal-title":"Eur J Pediatr"},{"key":"7102_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12882-024-03632-9","volume":"25","author":"S Liu","year":"2024","unstructured":"Liu S, Wan Y, Hu Z et al (2024) Nephrotic syndrome associated with solid malignancies: a systematic review. BMC Nephrol 25:215. https:\/\/doi.org\/10.1186\/s12882-024-03632-9","journal-title":"BMC Nephrol"},{"key":"7102_CR43","doi-asserted-by":"publisher","first-page":"26886","DOI":"10.1038\/s41598-024-77720-z","volume":"14","author":"E Russo","year":"2024","unstructured":"Russo E, Gambella M, Raiola AM et al (2024) Acute kidney injury in hematological patients treated with CAR-T cells: risk factors, clinical presentation and impact on outcomes. Sci Rep 14:26886. https:\/\/doi.org\/10.1038\/s41598-024-77720-z","journal-title":"Sci Rep"},{"key":"7102_CR44","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s00467-024-06302-y","volume":"39","author":"M Lopez-Gonzalez","year":"2024","unstructured":"Lopez-Gonzalez M, Ariceta G (2024) WT1-related disorders: more than Denys-Drash syndrome. Pediatr Nephrol 39:2601\u20132609. https:\/\/doi.org\/10.1007\/s00467-024-06302-y","journal-title":"Pediatr Nephrol"},{"key":"7102_CR45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1203\/01.pdr.0000196717.94518.f0","volume":"59","author":"B Mucha","year":"2006","unstructured":"Mucha B, Ozaltin F, Hinkes BG et al (2006) Mutations in the Wilms\u2019 tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 59:325\u2013331. https:\/\/doi.org\/10.1203\/01.pdr.0000196717.94518.f0","journal-title":"Pediatr Res"},{"key":"7102_CR46","unstructured":"Leslie SW, Sajjad H, Murphy PB, Wilms T (2023) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025:28723033"},{"key":"7102_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jtct.2025.03.007","volume":"31","author":"K Sadowski","year":"2025","unstructured":"Sadowski K, Ploch W, Downar A et al (2025) Nephrotoxicity in CAR-T cell therapy. Transplant Cell Ther 31:407\u2013418. https:\/\/doi.org\/10.1016\/j.jtct.2025.03.007","journal-title":"Transplant Cell Ther"},{"key":"7102_CR48","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2016.57.2.532","volume":"57","author":"YT Lim","year":"2016","unstructured":"Lim YT, Kim Y-J, Park YH et al (2016) A case of dasatinib-induced nephrotic syndrome in a child with Philadelphia chromosome positive acute lymphoblastic leukemia. Yonsei Med J 57:532. https:\/\/doi.org\/10.3349\/ymj.2016.57.2.532","journal-title":"Yonsei Med J"},{"key":"7102_CR49","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1007\/s00467-004-1591-0","volume":"19","author":"M Bhatia","year":"2004","unstructured":"Bhatia M, Kher K, Minniti CP (2004) Acute lymphoblastic leukemia in a child with nephrotic syndrome. Pediatr Nephrol 19:1290\u20131293. https:\/\/doi.org\/10.1007\/s00467-004-1591-0","journal-title":"Pediatr Nephrol"},{"key":"7102_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.amjms.2023.09.005","volume":"366","author":"J Li","year":"2023","unstructured":"Li J, Li X-L, Li C-Q (2023) Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney. Am J Med Sci 366:404\u2013412. https:\/\/doi.org\/10.1016\/j.amjms.2023.09.005","journal-title":"Am J Med Sci"},{"key":"7102_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1681\/ASN.2018080853","volume":"30","author":"CC Estrada","year":"2019","unstructured":"Estrada CC, Maldonado A, Mallipattu SK (2019) Therapeutic inhibition of VEGF signaling and associated nephrotoxicities. J Am Soc Nephrol 30:187\u2013200. https:\/\/doi.org\/10.1681\/ASN.2018080853","journal-title":"J Am Soc Nephrol"},{"key":"7102_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","volume":"46","author":"H Izzedine","year":"2010","unstructured":"Izzedine H, Massard C, Spano JP et al (2010) VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management. Eur J Cancer 46:439\u2013448. https:\/\/doi.org\/10.1016\/j.ejca.2009.11.001","journal-title":"Eur J Cancer"},{"key":"7102_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9086570","volume":"2019","author":"G Beziat","year":"2019","unstructured":"Beziat G, Tavitian S, Picard M et al (2019) Multiple severe toxicities of L-asparaginase and their innovative management during induction therapy of acute lymphoblastic leukemia in an adult patient. Case Rep Hematol 2019:9086570. https:\/\/doi.org\/10.1155\/2019\/9086570","journal-title":"Case Reports in Hematology"},{"key":"7102_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcped.2025.100225","volume":"5","author":"M Vieira Martins","year":"2025","unstructured":"Vieira Martins M, Buhl Rasmussen AS, Heldrup J et al (2025) Therapeutic drug monitoring in the treatment of childhood acute lymphoblastic leukemia \u2013 a practical guideline. EJC Paediatr Oncol 5:100225. https:\/\/doi.org\/10.1016\/j.ejcped.2025.100225","journal-title":"EJC Paediatr Oncol"},{"key":"7102_CR55","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/ndt\/gfi059","volume":"20","author":"A El-Husseini","year":"2005","unstructured":"El-Husseini A, El-Basuony F, Mahmoud I et al (2005) Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrol Dial Transplant 20:2433\u20132438. https:\/\/doi.org\/10.1093\/ndt\/gfi059","journal-title":"Nephrol Dial Transplant"},{"key":"7102_CR56","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S0022-3476(82)80536-2","volume":"100","author":"JR Priest","year":"1982","unstructured":"Priest JR, Ramsay NKC, Bennett AJ et al (1982) The effect of l-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr 100:990\u2013995. https:\/\/doi.org\/10.1016\/S0022-3476(82)80536-2","journal-title":"J Pediatr"},{"key":"7102_CR57","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.kint.2023.02.022","volume":"103","author":"G Malakasioti","year":"2023","unstructured":"Malakasioti G, Iancu D, Milovanova A et al (2023) A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants. Kidney Int 103:962\u2013972. https:\/\/doi.org\/10.1016\/j.kint.2023.02.022","journal-title":"Kidney Int"},{"key":"7102_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0971-4065.107197","volume":"23","author":"A Sinha","year":"2013","unstructured":"Sinha A, Sharma A, Mehta A et al (2013) Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome. Indian J Nephrol 23:41. https:\/\/doi.org\/10.4103\/0971-4065.107197","journal-title":"Indian J Nephrol"},{"key":"7102_CR59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12887-024-04633-1","volume":"24","author":"O Febvey-Combes","year":"2024","unstructured":"Febvey-Combes O, Guitton J, Marec-Berard P et al (2024) Renal toxicity of ifosfamide in children with cancer: an exploratory study integrating aldehyde dehydrogenase enzymatic activity data and a wide-array urinary metabolomics approach. BMC Pediatr 24:196. https:\/\/doi.org\/10.1186\/s12887-024-04633-1","journal-title":"BMC Pediatr"},{"key":"7102_CR60","doi-asserted-by":"publisher","unstructured":"Santos MLC, de Brito BB, da Silva FAF et al (2020) Nephrotoxicity in cancer treatment: an overview. World J Clin Oncol 11:190\u2013204. https:\/\/doi.org\/10.5306\/wjco.v11.i4.190","DOI":"10.5306\/wjco.v11.i4.190"},{"key":"7102_CR61","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/imj.13098","volume":"46","author":"E Wong","year":"2016","unstructured":"Wong E, Lasica M, He SZ et al (2016) Nephrotic syndrome as a complication of chronic graft-versus-host disease after allogeneic haemopoietic stem cell transplantation. Intern Med J 46:737\u2013741. https:\/\/doi.org\/10.1111\/imj.13098","journal-title":"Intern Med J"},{"key":"7102_CR62","doi-asserted-by":"publisher","first-page":"S264","DOI":"10.1016\/j.bbmt.2013.12.446","volume":"20","author":"B Dhakal","year":"2014","unstructured":"Dhakal B, Cohen EP, Palmer J, Hari PN (2014) Chronic graft versus host disease presenting as nephrotic syndrome. Biol Blood Marrow Transplant 20:S264\u2013S265. https:\/\/doi.org\/10.1016\/j.bbmt.2013.12.446","journal-title":"Biol Blood Marrow Transplant"},{"key":"7102_CR63","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5414\/CN107420","volume":"80","author":"J Huskey","year":"2013","unstructured":"Huskey J, Rivard C, Myint H et al (2013) Minimal change disease in graft versus host disease: a podocyte response to the graft? Clin Nephrol 80:469\u2013473. https:\/\/doi.org\/10.5414\/CN107420","journal-title":"Clin Nephrol"},{"key":"7102_CR64","first-page":"373","volume":"18","author":"A Pourtsidis","year":"2014","unstructured":"Pourtsidis A, Doganis D, Baka M et al (2014) Nephrotic syndrome and Hodgkin lymphoma in children. Report of two cases. Hippokratia 18:373\u2013375","journal-title":"Hippokratia"},{"key":"7102_CR67","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/joneph\/20.5.626","volume":"20","author":"E Gonz\u00e1lez Garc\u00eda","year":"2007","unstructured":"Gonz\u00e1lez Garc\u00eda E, Olea T, Hevia C et al (2007) Focal segmental glomerulosclerosis due to a relapsing non-Hodgkin\u2019s lymphoma diagnosed by positron emission tomography. J Nephrol 20:626\u2013628","journal-title":"J Nephrol"},{"key":"7102_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-211765","volume":"2015","author":"S Hindocha","year":"2015","unstructured":"Hindocha S, Gopaluni S, Collins GP, Shenbagaraman P (2015) Focal segmental glomerulosclerosis in a patient with mantle cell lymphoma. BMJ Case Rep 2015:bcr2015211765. https:\/\/doi.org\/10.1136\/bcr-2015-211765","journal-title":"BMJ Case Rep"},{"key":"7102_CR69","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3339\/jkspn.2018.22.2.91","volume":"22","author":"SH Kim","year":"2018","unstructured":"Kim SH, Park H-M, Lee JH et al (2018) A case of infantile nephrotic syndrome associated with neuroblastoma. Child Kidney Dis 22:91\u201396. https:\/\/doi.org\/10.3339\/jkspn.2018.22.2.91","journal-title":"Child Kidney Dis"},{"key":"7102_CR70","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/01.mph.0000139454.22338.17","volume":"26","author":"JB Posner","year":"2004","unstructured":"Posner JB (2004) Paraneoplastic syndromes in neuroblastoma. J Pediatr Hematol Oncol 26:553\u2013554. https:\/\/doi.org\/10.1097\/01.mph.0000139454.22338.17","journal-title":"J Pediatr Hematol Oncol"},{"key":"7102_CR71","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12882-020-02136-6","volume":"21","author":"H-CG Wu","year":"2020","unstructured":"Wu H-CG, Cheng C-N, Chen J-S, Chiou Y-Y (2020) Rhabdomyosarcoma in a child with nephrotic syndrome treated with cyclosporine: a case report with literature review. BMC Nephrol 21:490. https:\/\/doi.org\/10.1186\/s12882-020-02136-6","journal-title":"BMC Nephrol"},{"key":"7102_CR72","doi-asserted-by":"publisher","first-page":"A1472","DOI":"10.1016\/j.chest.2019.08.1306","volume":"156","author":"L Pappy","year":"2019","unstructured":"Pappy L, Bernstein M, Babayev R (2019) Concurrent thymoma and nephrotic syndrome: a rare simultaneous finding. Chest 156:A1472. https:\/\/doi.org\/10.1016\/j.chest.2019.08.1306","journal-title":"Chest"},{"key":"7102_CR73","doi-asserted-by":"publisher","first-page":"647","DOI":"10.51219\/MCCRJ\/Elisavet-Kanna\/167","volume":"3","author":"E Kanna","year":"2025","unstructured":"Kanna E, Lamprinou Z, Skondras I et al (2025) Paraneoplastic nephrotic syndrome in a teenager with ovarian teratoma: successful treatment with tumor resection and ovarian tissue preservation. Medical & Clinical Case Reports Journal 3:647\u2013649. https:\/\/doi.org\/10.51219\/MCCRJ\/Elisavet-Kanna\/167","journal-title":"Medical & Clinical Case Reports Journal"},{"key":"7102_CR74","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12288-012-0185-4","volume":"30","author":"D Joseph","year":"2014","unstructured":"Joseph D, Biswajit D, Ganesh RN et al (2014) Paediatric T cell lymphoma with nephrotic syndrome: a rare association. Indian J Hematol Blood Transfus 30:45\u201347. https:\/\/doi.org\/10.1007\/s12288-012-0185-4","journal-title":"Indian J Hematol Blood Transfus"},{"key":"7102_CR77","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E et al (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877\u2013919. https:\/\/doi.org\/10.1007\/s00467-022-05739-3","journal-title":"Pediatr Nephrol"},{"key":"7102_CR78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/20469047.2017.1374003","volume":"37","author":"ML Downie","year":"2017","unstructured":"Downie ML, Gallibois C, Parekh RS, Noone DG (2017) Nephrotic syndrome in infants and children: pathophysiology and management. Paediatr Int Child Health 37:248\u2013258. https:\/\/doi.org\/10.1080\/20469047.2017.1374003","journal-title":"Paediatr Int Child Health"},{"key":"7102_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19095301","volume":"19","author":"I Smarz-Widelska","year":"2022","unstructured":"Smarz-Widelska I, Choj\u0119ta D, Kozio\u0142 MM (2022) The role of anti-PLA2R and anti-THSD7A antibodies in the pathogenesis and diagnostics of primary membranous nephropathy: a review of current knowledge for clinical practice. Int J Environ Res Public Health 19:5301. https:\/\/doi.org\/10.3390\/ijerph19095301","journal-title":"Int J Environ Res Public Health"},{"key":"7102_CR80","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1681\/ASN.2017020178","volume":"28","author":"LH Beck","year":"2017","unstructured":"Beck LH (2017) PLA2R and THSD7A: disparate paths to the same disease? J Am Soc Nephrol 28:2579\u20132589. https:\/\/doi.org\/10.1681\/ASN.2017020178","journal-title":"J Am Soc Nephrol"},{"key":"7102_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf012","volume":"18","author":"Q Chen","year":"2025","unstructured":"Chen Q, Chen S, Ye Q et al (2025) Anti-nephrin antibody: a potential biomarker of minimal change disease. Clin Kidney J 18:sfaf012. https:\/\/doi.org\/10.1093\/ckj\/sfaf012","journal-title":"Clin Kidney J"},{"key":"7102_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-017-9153-1","volume":"14","author":"YW Choi","year":"2017","unstructured":"Choi YW, Kim YG, Song M-Y et al (2017) Potential urine proteomics biomarkers for primary nephrotic syndrome. Clin Proteomics 14:18. https:\/\/doi.org\/10.1186\/s12014-017-9153-1","journal-title":"Clin Proteomics"},{"key":"7102_CR83","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60089","author":"L Yu","year":"2024","unstructured":"Yu L, Wang J, Feng C et al (2024) A child with concomitant neuroblastoma and IgA nephropathy: a case report and literature review. Cureus. https:\/\/doi.org\/10.7759\/cureus.60089","journal-title":"Cureus"},{"key":"7102_CR84","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2215\/CJN.08570722","volume":"18","author":"EY-H Chan","year":"2023","unstructured":"Chan EY-H, Yap DY-H, Colucci M et al (2023) Use of rituximab in childhood idiopathic nephrotic syndrome. Clin J Am Soc Nephrol 18:533\u2013548. https:\/\/doi.org\/10.2215\/CJN.08570722","journal-title":"Clin J Am Soc Nephrol"},{"key":"7102_CR85","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.ekir.2023.05.022","volume":"8","author":"B Basu","year":"2023","unstructured":"Basu B, Erdmann S, Sander A et al (2023) Long-term efficacy and safety of rituximab versus tacrolimus in children with steroid dependent nephrotic syndrome. Kidney Int Rep 8:1575\u20131584. https:\/\/doi.org\/10.1016\/j.ekir.2023.05.022","journal-title":"Kidney Int Rep"},{"key":"7102_CR86","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12882-024-03739-z","volume":"25","author":"GS Dhooria","year":"2024","unstructured":"Dhooria GS, Bhargava S, Bhat D et al (2024) Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study. BMC Nephrol 25:296. https:\/\/doi.org\/10.1186\/s12882-024-03739-z","journal-title":"BMC Nephrol"},{"key":"7102_CR87","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12882-021-02605-6","volume":"22","author":"M Haddad","year":"2021","unstructured":"Haddad M, Kale A, Butani L (2021) Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease. BMC Nephrol 22:395. https:\/\/doi.org\/10.1186\/s12882-021-02605-6","journal-title":"BMC Nephrol"},{"key":"7102_CR88","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ki.2009.412","volume":"77","author":"J Radhakrishnan","year":"2010","unstructured":"Radhakrishnan J, Moutzouris D-A, Ginzler EM et al (2010) Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. Kidney Int 77:152\u2013160. https:\/\/doi.org\/10.1038\/ki.2009.412","journal-title":"Kidney Int"},{"key":"7102_CR89","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00467-024-06605-0","volume":"40","author":"CH Robinson","year":"2025","unstructured":"Robinson CH, Aman N, Banh T et al (2025) Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a cohort study. Pediatr Nephrol 40:1625\u20131634. https:\/\/doi.org\/10.1007\/s00467-024-06605-0","journal-title":"Pediatr Nephrol"},{"key":"7102_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00178","volume":"7","author":"M Kallash","year":"2019","unstructured":"Kallash M, Smoyer WE, Mahan JD (2019) Rituximab use in the management of childhood nephrotic syndrome. Front Pediatr 7:178. https:\/\/doi.org\/10.3389\/fped.2019.00178","journal-title":"Front Pediatr"},{"key":"7102_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.626323","volume":"9","author":"X Gao","year":"2021","unstructured":"Gao X, Wang Y, Xu Z et al (2021) Systematic review and meta-analysis of rituximab for steroid-dependent or frequently relapsing nephrotic syndrome in children. Front Pediatr 9:626323. https:\/\/doi.org\/10.3389\/fped.2021.626323","journal-title":"Front Pediatr"},{"key":"7102_CR92","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.005167","volume":"5","author":"S Eren Akarcan","year":"2018","unstructured":"Eren Akarcan S, Edeer Karaca N, Aksu G et al (2018) Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome. JMM Case Rep 5:e005167. https:\/\/doi.org\/10.1099\/jmmcr.0.005167","journal-title":"JMM Case Rep"},{"key":"7102_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.619548","volume":"8","author":"CL Tran","year":"2021","unstructured":"Tran CL, Selewski DT, Oh GJ et al (2021) Pediatric immunization practices in nephrotic syndrome: an assessment of provider and parental knowledge. Front Pediatr 8:619548. https:\/\/doi.org\/10.3389\/fped.2020.619548","journal-title":"Front Pediatr"},{"key":"7102_CR94","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fped.2019.00339","volume":"7","author":"ST Goonewardene","year":"2019","unstructured":"Goonewardene ST, Tang C, Tan LT-H et al (2019) Safety and efficacy of pneumococcal vaccination in pediatric nephrotic syndrome. Front Pediatr 7:339. https:\/\/doi.org\/10.3389\/fped.2019.00339","journal-title":"Front Pediatr"},{"key":"7102_CR95","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.kint.2025.04.015","volume":"108","author":"S Habbig","year":"2025","unstructured":"Habbig S, Debiec H, Chedik M et al (2025) Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis. Kidney Int 108:321\u2013327. https:\/\/doi.org\/10.1016\/j.kint.2025.04.015","journal-title":"Kidney Int"},{"key":"7102_CR96","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-022-00816-y","volume":"23","author":"H-J Anders","year":"2023","unstructured":"Anders H-J, Kitching AR, Leung N, Romagnani P (2023) Glomerulonephritis: immunopathogenesis and immunotherapy. Nat Rev Immunol 23:453\u2013471. https:\/\/doi.org\/10.1038\/s41577-022-00816-y","journal-title":"Nat Rev Immunol"},{"key":"7102_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112978","volume":"11","author":"C Gluhovschi","year":"2023","unstructured":"Gluhovschi C, Gadalean F, Velciov S et al (2023) Three diseases mediated by different immunopathologic mechanisms\u2014ANCA-associated vasculitis, anti-glomerular basement membrane disease, and immune complex-mediated glomerulonephritis\u2014a common clinical and histopathologic picture: rapidly progressive crescentic glomerulonephritis. Biomedicines 11:2978. https:\/\/doi.org\/10.3390\/biomedicines11112978","journal-title":"Biomedicines"},{"key":"7102_CR98","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s00467-025-06735-z","volume":"40","author":"Y Inoki","year":"2025","unstructured":"Inoki Y, Horinouchi T, Aoyama S et al (2025) Differences in kidney prognosis between congenital and infantile nephrotic syndrome. Pediatr Nephrol 40:2539\u20132549. https:\/\/doi.org\/10.1007\/s00467-025-06735-z","journal-title":"Pediatr Nephrol"},{"key":"7102_CR99","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s00467-025-06778-2","volume":"40","author":"D Mazza","year":"2025","unstructured":"Mazza D, Ward E, Makeneni S et al (2025) Association of COVID-19 vaccination with relapsed nephrotic syndrome and new onset nephrotic syndrome in children. Pediatr Nephrol 40:2855\u20132862. https:\/\/doi.org\/10.1007\/s00467-025-06778-2","journal-title":"Pediatr Nephrol"},{"key":"7102_CR100","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ekir.2024.11.028","volume":"10","author":"G Bianchi","year":"2025","unstructured":"Bianchi G, Morello W, Pesce E et al (2025) Detection of antinephrin antibodies in childhood idiopathic nephrotic syndrome. Kidney Int Rep 10:605\u2013609. https:\/\/doi.org\/10.1016\/j.ekir.2024.11.028","journal-title":"Kidney Int Rep"},{"key":"7102_CR101","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.3390\/cancers15143608","volume":"15","author":"X Jiang","year":"2023","unstructured":"Jiang X, Hu Z, Wang S, Zhang Y (2023) Deep learning for medical image-based cancer diagnosis. Cancers (Basel) 15:3608. https:\/\/doi.org\/10.3390\/cancers15143608","journal-title":"Cancers (Basel)"},{"key":"7102_CR75","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0022-3468(05)80005-3","volume":"25","author":"ES Tank","year":"1990","unstructured":"Tank ES, Melvin T (1990) The association of Wilms\u2019 tumor with nephrologic disease. J Pediatr Surg 25:724\u2013725. https:\/\/doi.org\/10.1016\/S0022-3468(05)80005-3","journal-title":"J Pediatr Surg"},{"key":"7102_CR76","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1046\/j.1523-1755.1998.00948.x","volume":"53","author":"V Schumacher","year":"1998","unstructured":"Schumacher V, Sch\u00e4rer K, W\u00fchl E et al (1998) Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 53:1594\u20131600. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00948.x","journal-title":"Kidney Int"},{"key":"7102_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.868715","volume":"10","author":"M Hu","year":"2022","unstructured":"Hu M, Wang Q, Liu B, Ma Q, Zhang T, Huang T, Lv Z, Wang R (2022) Chronic kidney disease and cancer: inter-relationships and mechanisms. Front Cell Dev Biol 10:868715","journal-title":"Front Cell Dev Biol"},{"key":"7102_CR66","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/s41390-022-02336-w","volume":"93","author":"J Liu","year":"2023","unstructured":"Liu J, Guan F (2023) B cell phenotype, activity, and function in idiopathic nephrotic syndrome. Pediatr Res 93:1828\u20131836. https:\/\/doi.org\/10.1038\/s41390-022-02336-w","journal-title":"Pediatr Res"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07102-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-07102-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07102-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:06:14Z","timestamp":1785452774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-07102-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7102"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-07102-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is a narrative review and does not involve the use of human participants or animal subjects in original research; therefore, ethical approval and informed consent were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this review does not contain personal data, images, or identifiable information from individuals, consent for publication is not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}